S. Bernardini

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival

ESPEN guideline: Clinical nutrition in surgery

Cushing's syndrome

Guidelines on Bladder Cancer

Initial High-Grade T1 Urothelial Cell Carcinoma: Feasibility and Prognostic Significance of Lamina Propria Invasion Microstaging (T1a/b/c) in BCG-Treated and BCG-Non-Treated Patients

A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?

New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer

Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines

N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

Predictive factors of recurrence and survival of upper tract urothelial carcinomas

Pathobiology of Pituitary Adenomas and Carcinomas

Effects of Obesity on Kidney Transplantation Outcomes

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Bladder cancer

Corticotroph carcinoma of the pituitary: a clinicopathological study

The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi‐institutional collaborative study

P53 as a prognostic marker for bladder cancer: a meta-analysis and review

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

Artificial intelligence in medicine

Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study

EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

Comparing Expert Reported Outcomes to National Surgical Quality Improvement Program Risk Calculator-Predicted Outcomes: Do Reporting Standards Differ?

Natural History, Recurrence, and Progression in Superficial Bladder Cancer

The Fibroblast Growth Factor signaling pathway

Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers

Nanomaterials and nanoparticles: Sources and toxicity

Identification and Prognostic Significance of an Epithelial-Mesenchymal Transition Expression Profile in Human Bladder Tumors

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

Combination therapy in combating cancer

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials

Smoking‐gene Interaction and Disease Development: Relevance to Pancreatic Cancer and Atherosclerosis

Endocan Is Upregulated on Tumor Vessels in Invasive Bladder Cancer Where It Mediates VEGF-A–Induced Angiogenesis

Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization

Epithelial–mesenchymal transition promotes SOX2 and NANOG expression in bladder cancer

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Systematic reviews: CRD's guidance for undertaking reviews in health care

Bilan et prise en charge d’une tumeur de la voie excrétrice urinaire supérieure en 2010 : mise au point du comité de cancérologie de l’Association francaise d’urologie

Outcomes of Renal Transplantation in Obese Recipients

THE PREDICTIVE VALUE OF MUSCULARIS MUCOSAE INVASION AND p53 OVER EXPRESSION ON PROGRESSION OF STAGE T1 BLADDER CARCINOMA

Tumeurs urothéliales

IMMUNOHISTOCHEMICAL DETECTION OF p53 PROTEIN OVEREXPRESSION VERSUS GENE SEQUENCING IN URINARY BLADDER CARCINOMAS

N-Cadherin as a Novel Prognostic Marker of Progression in Superficial Urothelial Tumors

Influence of cigarette smoking on P53 gene mutations in bladder carcinomas.

SERUM LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AS A PROGNOSTIC FACTOR IN BLADDER CANCER